An in-depth look to EXACT THERAP. AS NK 0,004 operating, investing, and financing activities

56F free cash flow for H1 24 is -2.66 M EUR. For 2023, 56F free cash flow was -4.13 M EUR and operating cash flow was -3.86 M EUR.